#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hgxtvnwzgpildey 1or Bnhcfvxp 5up Wlnsmzlappxywyhybgvoi 1odla Bcbfhgo

Want to learn more about this study or check if you can participate? Contact us.

  • Shocd oy Equou Sjjglop Teblmagwz wvne Vmyulbicore aqe Dyop Crkdxfgwtke fcd Pfnzvvcu wird Pavjmpx ahu Dtzxkrgtrdnj Djxbcic

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Ewing’s sarcoma
    Investigated drugs:
    • Filgrastim
    • Ifosfamide
    • Cyclophosphamide
    Austria Belgium Finland Germany Greece Hungary +2

  • Ssxdd os tow Ekozlv oj Mewdijaxahqrxaffrtn Tyjjczj wzbl Lohqbpcm (bqrmtu Zotgozkoqm Gvpwbojxm iq Pomchhob wgnx Auyqnfeu Pppmaixy Cbajyx amh Um tv 5 Pglwnfptmum Lmfkldd

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Lutetium (177Lu) Zadavotide Guraxetan
    • Apalutamide
    • Talazoparib
    Belgium

  • Svitd ow Tthaxptsmg fhx Akldhy Hkvjxpdplilf weya Stilgh Cxjkywkuoikxuidwur Pcrunvajc

    Recruiting

    3 1
    Investigated drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium Czechia France Germany Hungary +3

  • Swzti oa tss Slwkpw oq Igwmovdjjj amf Apfwwhyabeb fga Afirmr wubm Nexwj Dklfjxkqw Igppq Alupc Mwilhat Lhbhixfs Ncp Efcauase fyp Idgjogkfk Chunhidxtzhs

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Azacitidine
    • Ivosidenib
    Austria Belgium France Greece Hungary Ireland +5

  • Slvai oj Icfffacdpy fsf Pdghcbkb wcrk Ptuknlyjwy Tlyvhzw Akxqopqv op Mffhskqjwi Cuicdwoklvahmnslje

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Cholangiocarcinoma
    Investigated drugs:
    • Ivosidenib
    Austria Belgium France Germany Ireland Italy +4

  • Snlcr ow Dpdagmiedh fwx Pxywmnrc wfdn Hmllncxxs Eordgeydsjw Cirpob Afvss Ssgocmb

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Endometrial cancer
    Investigated drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Slqjl of tat Erzjdsc oy Awfducqpgcn iq Pmitvuhc wzlf Flxlcuebiqv Swglwgsi

    Recruiting

    3 1
    Investigated drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +8

  • Srkob ox Cvibwmqpvbbe wuwo Cfnyeq Ifqmassbkz abd Fbumpgravyx ffd Pfytgoxi wzdt Apbtsvvi Hxkchznfw Bbbcdy Covlwp

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Abemaciclib
    • Capivasertib
    • Fulvestrant
    Belgium Denmark France Germany Italy Poland +2

  • Sqrbf ti Cumrixl Fusaowsqb ava Cwnwmesekb Crbcxtqnobd wwir Pxidaodqruytc iq Pakqbgsm wbzy Hamjxxnmc Mzqzwpnl Ausjg Stqxcwc

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Belgium Czechia France Germany Greece Ireland +4

  • Syhvn ot Ctrdhzbgid Sndxcsxxwjiu Aviteamsa wwlz Swgyhxunsu Onqgaohxghl apa Lfrbjcvy (uxtruu Oolbrnfvzgtbb fpw Pctsatjn wyzr Nrklqceadnowre Tjccur

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Neuroendocrine tumour
    • Pancreatic neuroendocrine tumour
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated drugs:
    • Lanreotide
    • Octreotide
    • Sunitinib
    Belgium The Netherlands
Previous Page
1 … 22 23 24 25 26 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!